Medication adherence among HIV-infected individuals is critical to limit disease progression and onward transmission. Evidence indicates that among youth living with HIV (YLH), adherence is suboptimal and related to co-morbid psychosocial conditions. Cross-sectional data from 212 YLH, ages 16–29, collected between 2011–2014 in Chicago were analyzed to assess the relationship of multiple psychosocial conditions (e.g., depressive symptoms, anxiety symptoms, moderate/heavy marijuana use, moderate/heavy alcohol use, HIV-related stigma) to ART adherence (i.e., a “syndemic.”) Adherence was regressed on an index of increasing numbers of psychosocial conditions, controlling for demographic and treatment factors as well as enrollment site. The mean age of participants was 24, 89% were male, 87% black, and 91% behaviorally infected. Psychosocial conditions were prevalent, including 38% and 34% with high depressive and anxiety symptoms, respectively, 54% and 25% with a moderate/high level of marijuana and alcohol use, respectively, and 46% reporting high HIV-related stigma. In regression analysis, the likelihood of ART adherence decreased with the number of syndemic conditions (linear dose response, p = 0.02) as did the odds of viral load suppression (p = 0.008). Interventions to address these conditions in concert with biomedical treatment as prevention for YLH are needed.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control and Prevention. HIV surveillance report, 2013. Atlanta GA. 2013.
2.
White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: Updated to 2020. Washington, DC, 2015.
3.
OsterbergL, BlaschkeT. Adherence to medication. N Engl J Med, 2005; 353:487–497.
4.
BangsbergDR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis, 2006; 43:939–941.
5.
ParientiJJ, Das-DouglasM, MassariV, et al.Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PloS One, 2008; 3:e2783.
6.
FeingoldA, RutsteinR, MeislichD, BrownT, RudyB. Protease inhibitor therapy in HIV-infected children. AIDS Patient Care STDS, 2000; 14:589–593.
7.
FlynnP, RudyB, DouglasS, et al.Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis, 2004; 190:271–279.
8.
GrossR, BilkerWB, FriedmanHM, StromBL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS, 2001; 15:2109–2117.
9.
LafeuilladeA, TamaletC, PellegrinoP, De MiccoP, VignoliC, QuilichiniR. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acq Immune Defic Syndr, 1994; 7:1028–1033.
10.
McNabbJ, RossJ, AbriolaK, TurleyC, NightingaleC, NicolauD. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis, 2001; 33:700–705.
11.
MurphyD, BelzerM, DurakoS, MoussaS, WilsonC, MuenzL. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med, 2005; 159:764–770.
12.
RaoD, KekwaletsweT, HosekS, MartinezJ, RodriguezF. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care, 2007; 19:28–33.
13.
ReisnerSL, MimiagaMJ, SkeerM, PerkovichB, JohnsonCV, SafrenSA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med, 2009; 17:14–25.
14.
KimSH, GerverSM, FidlerS, WardH. Adherence to antiretroviral therapy in adolescents living with HIV: Systematic review and meta-analysis. AIDS, 2014; 28:1945–1956.
15.
HosekSG, HarperGW, DomanicoR. Predictors of medication adherence among HIV-infected youth. Psychol Health Med, 2005; 10:166–179.
16.
MurphyD, WilsonC, DurakoS, MuenzL, BelzerM. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care, 2001; 13:27–40.
17.
WilliamsP, StormD, MontepiedraG, et al.Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics, 2006; 118:e1745–e1757.
18.
ComuladaW, SwendemanD, Rotheram-BorusM, MattesK, WeissR. Young people living with HIV. Am J Health Behav, 2003; 27:389–400.
19.
BrownLK, WhiteleyL, HarperGW, NicholsS, NievesA, Adolescent Med Trials Network HIV. Psychological symptoms among 2032 youth living with HIV: A multisite study. AIDS Patient Care STDS, 2015; 29:212–219.
20.
PaoM, LyonM, D'AngeloLJ, SchumanWB, TipnisT, MrazekDA. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med, 2000; 154:240–244.
21.
Naar-KingS, KolmodinK, ParsonsJT, MurphyD, ATN 004 Protocol Team Adolescent Trials Network for HIV/AIDS Interventions. Psychosocial factors and substance use in high-risk youth living with HIV: A multi-site study. AIDS Care, 2010; 22:475–482.
22.
NugentNR, BrownLK, BelzerM, HarperGW, NachmanS, Naar-KingS. Youth living with HIV and problem substance use: Elevated distress is associated with nonadherence and sexual risk. J Intl Assoc Physicians AIDS Care, 2010; 9:113–115.
23.
TanneyMR, Naar-KingS, MurphyDA, ParsonsJT, JanisseH. Multiple risk behaviors among youth living with human immunodeficiency virus in five U.S. cities. J Adolesc Health, 2010; 46:11–16.
24.
MerrillS. Introducing Syndemics: A Critical Systems Approach to Public and Community Health. Wiley, 2009.
25.
BrennanJ, KuhnsLM, JohnsonAK, BelzerM, WilsonEC, GarofaloR. Syndemic theory and HIV-related risk among young transgender women: The role of multiple, co-occurring health problems and social marginalization. Am J Public Health, 2012; 102:1751–1757.
26.
MustanskiB, GarofaloR, HerrickA, DonenbergG. Psychosocial health problems increase risk for HIV among urban young men who have sex with men: Preliminary evidence of a syndemic in need of attention. Ann Behav Med, 2007; 34:37–45.
27.
StallR, FriedmanM, CataniaJ. Interacting epidemics and gay men's health: A theory of syndemic production among urban gay men. In: WolitskiRJ, StallR, ValdiserriRO, eds. Unequal Opportunity: Health Disparities Affecting Gay and Bisexual Men in the United States. New York: Oxford University Press, 2007.
28.
HalkitisPN, KapadiaF, BubKL, BartonS, MoreiraAD, StultsCB. A longitudinal investigation of syndemic conditions among young gay, bisexual, and other MSM: The P18 Cohort Study. AIDS Behav, 2015; 19:970–980.
29.
HerrickA, StallR, EganJ, SchragerS, KipkeM. Pathways towards risk: Syndemic conditions mediate the effect of adversity on HIV risk behaviors among young men who have sex with men (YMSM). J Urban Health, 2014; 91:969–982.
30.
MimiagaMJ, O'CleirighC, BielloKB, et al.The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men. J Acq Immune Def Syndr (1999), 2015; 68:329–336.
31.
O'LearyA, JemmottJB3rd, StevensR, RutledgeSE, IcardLD. Optimism and education buffer the effects of syndemic conditions on HIV status among African American men who have sex with men. AIDS Behav, 2014; 18:2080–2088.
32.
WilsonPA, NaninJ, AmestyS, WallaceS, CherenackEM, FulliloveR. Using syndemic theory to understand vulnerability to HIV infection among Black and Latino men in New York City. J Urban Health, 2014; 91:983–998.
33.
BlashillAJ, BedoyaCA, MayerKH, et al.Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav, 2015; 19:981–986.
34.
Chicago Department of Public Health. HIV/STI surveillance report. Chicago: Chicago Department of Public Health, 2014.
35.
GarofaloR, KuhnsLM, HottonA, JohnsonA, MuldoonA, RiceD. A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav 11; 2015 (in press).
36.
BourisA, VoisinD, PillotonM, et al.Project nGage: Network supported HIV care engagement for younger black men who have sex with men and transgender persons. J AIDS Clinical Res, 2014; 4:236.
37.
MurphyDA, SarrM, DurakoSJ, MoscickiAB, WilsonCM, MuenzLR. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med, 2003; 157:249–255.
38.
BelzerME, Naar-KingS, OlsonJ, et al.The use of cell phone support for non-adherent HIV-infected youth and young adults: An initial randomized and controlled intervention trial. AIDS Behav, 2014; 18:686–696.
39.
Naar-KingS, TemplinT, WrightK, FreyM, ParsonsJ, LamP. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDs, 2006; 20:44–47.
40.
WrightK, Naar-KingS, LamP, TemplinT, FreyM. Stigma scale revised: Reliability and validity of a brief measure of stigma for HIV+ youth. J Adolesc Health, 2007; 40:96–98.
41.
DerogatisL. Brief Symptom Inventory: Administration, Scoring, and Procedures Manual. Minneapolis, MN: National Computer Systems, Inc., 1993.
42.
HumeniukR. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and Pilot Brief Intervention: A Technical Report of Phase II Findings of the WHO ASSIST Project. Geneva: World Health Organization, 2006.
43.
DowshenN, KuhnsLM, JohnsonA, HoloydaBJ, GarofaloR. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: A pilot study using personalized, interactive, daily text message reminders. J Med Internet Res, 2012; 14:e51.
44.
Naar-KingS, OutlawAY, SarrM, et al.Motivational Enhancement System for Adherence (MESA): Pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol, 2013; 38:638–648.
45.
BelzerME, Kolmodin MacDonellK, ClarkLF, et al.Acceptability and feasibility of a cell phone support intervention for youth living with HIV with nonadherence to antiretroviral therapy. AIDS Patient Care STDS, 2015; 29:338–345.
46.
ThurstonIB, BogartLM, WachmanM, ClossonEF, SkeerMR, MimiagaMJ. Adaptation of an HIV medication adherence intervention for adolescents and young adults. Cogn Behav Pract, 2014; 21:191–205.
